Literature DB >> 18415237

[Postoperative analgesia with buprenorphine : A comparative study of epidural, patient-controlled intravenous and conventional subcutaneous administration.].

J Fähnrich1, C Castelano, E Sturzenegger, B Stoll, P Uehlinger, S Geroulanos.   

Abstract

Thirty patients who had undergone elective anterolateral thoracotomy were studied in the surgical intensive care unit to compare the analgesic effectiveness of i.v. self-administered buprenorphine (group A) with that of epidural administration (group B) and of s.c. administration by a nurse of 0.3 mg buprenorphine every 3-4 h (group C, controls). Every 2 h the patients were asked to record their subjektive pain level as a percentage on an analogue scale: zero was to be used for no pain and 100% for the most severe pain they could imagine. the mean of all analogue scores for pain in the first 36 h was 19.4+/-3.1 for group A; 18.4+/-2.3 for group B and 42.0+/-7.4 for group C (P<0.025). When the mean scores were referred to time, it seemed that groups A and B suffered a little more pain immediately after the operation; however, after 4 h the mean scores for these groups were far lower than that for the control group. The amount of buprenorphine used during the first 36 h was 0.036+/-0.006 mg/h per m(2) in group A, 0.021+/-0.002 mg/h per m(2) in group B and 0.038+0.004 mg/h in the control group. The mean interval between two injections was 9.47+/-1.4 h in group A, 2.47+0.5 h in group B, and 5.18+0.7 h in group C. It can be concluded that, at least in patients in an intensive care unit, scheduled administration of pain killers is unacceptable now. The self-administration device has shown the possibility of on-demand i.v. administration, which is no more dangerous than scheduled s.c. administration. Nurses should be instructed to provide analgesic medication on demand. Epidural administration of buprenorphine is superior to self-administration in terms of the amount of drugs used and the dosing intervals. In the quality of analgesia epidural administration and self-administration are equal and superior to the control procedure.

Entities:  

Year:  1990        PMID: 18415237     DOI: 10.1007/BF02527904

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  8 in total

1.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

2.  Cardiff Palliator.

Authors:  M Rosen; P Slattery; M D Vickers
Journal:  Br J Anaesth       Date:  1983-09       Impact factor: 9.166

Review 3.  Intrathecal and epidural administration of opioids.

Authors:  M J Cousins; L E Mather
Journal:  Anesthesiology       Date:  1984-09       Impact factor: 7.892

4.  Epidural buprenorphine.

Authors:  D J Murchison; F M Davis; J M Gibbs; E J Maycock
Journal:  Anaesth Intensive Care       Date:  1984-05       Impact factor: 1.669

5.  Patient-controlled analgesia: a new concept of postoperative pain relief.

Authors:  R L Bennett; R L Batenhorst; B A Bivins; R M Bell; D A Graves; T S Foster; B D Wright; W O Griffen
Journal:  Ann Surg       Date:  1982-06       Impact factor: 12.969

6.  [Pain diagnosis and pain measurement. II. Clinical aspects].

Authors:  J Bangert; W Tolksdorf
Journal:  Anasth Intensivther Notfallmed       Date:  1984-10

7.  [A double-blind comparison of epidural buprenorphine and epidural morphine in postoperative pain (author's transl)].

Authors:  M Zenz; S Piepenbrock; B Hübner; M Glocke
Journal:  Anasth Intensivther Notfallmed       Date:  1981-12

8.  Intramuscular on demand analgesia: double blind controlled trial of pethidine, buprenorphine, morphine, and meptazinol.

Authors:  M Harmer; P J Slattery; M Rosen; M D Vickers
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-26
  8 in total
  1 in total

1.  [Patient-controlled analgesia with piritramide for postoperative pain relief in general surgery: a prospective observational study.].

Authors:  B M Ure; K Ullmann; E Neugebauer; J Bende; H Troidl
Journal:  Schmerz       Date:  1993-03       Impact factor: 1.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.